Targeting the androgen receptor in triple-negative breast cancer: current perspectives

per Mina, Alain, Yoder, Rachel, Sharma, Priyanka
Publicat a Onco Targets Ther (2017)

Racial/Ethnic differences in the prevalence of anxiety using the Vanderbilt ADHD scale in a diverse community outpatient setting

per Bauer, Nerissa S., Yoder, Rachel, Carroll, Aaron E., Downs, Stephen M.
Publicat a J Dev Behav Pediatr (2016)

Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer

per Sharma, Priyanka, Abramson, Vandana G., O’Dea, Anne, Nye, Lauren, Mayer, Ingrid, Pathak, Harsh B., Hoffmann, Marc, Stecklein, Shane R., Elia, Manana, Lewis, Sharon, Scott, Jecinta, De Jong, Jilliann A., Wang, Yen Y., Yoder, Rachel, Schwensen, Kelsey, Finke, Karissa, Heldstab, Jaimie, LaFaver, Stephanie, Williamson, Stephen K., Phadnis, Milind, Reed, Gregory A., Kimler, Bruce F., Khan, Qamar J., Godwin, Andrew K.
Publicat a Clin Cancer Res (2021)

Randomized phase II trial of anthracycline-free and anthracycline-containing neoadjuvant carboplatin chemotherapy regimens in stage I-III triple-negative breast cancer (NeoSTOP)

per Sharma, Priyanka, Kimler, Bruce F., O’Dea, Anne, Nye, Lauren, Wang, Yen Y., Yoder, Rachel, Staley, Joshua M., Prochaska, Lindsey, Wagner, Jamie, Amin, Amanda L., Larson, Kelsey, Balanoff, Christa, Elia, Manana, Crane, Gregory, Madhusudhana, Sheshadri, Hoffmann, Marc, Sheehan, Maureen, Rodriguez, Roberto, Finke, Karissa, Shah, Rajvi, Satelli, Deepti, Shrestha, Anuj, Beck, Larry, McKittrick, Richard, Pluenneke, Robert, Raja, Vinay, Beeki, Venkatadri, Corum, Larry, Heldstab, Jaimie, LaFaver, Stephanie, Prager, Micki, Phadnis, Milind, Mudaranthakam, Dinesh Pal, Jensen, Roy A., Godwin, Andrew K., Salgado, Roberto, Mehta, Kathan, Khan, Qamar
Publicat a Clin Cancer Res (2020)